Aegon Ltd. vs Citius Pharmaceuticals Inc — how do they compare? Aegon Ltd. trades at $9.44 (market cap $14.01B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Aegon Ltd. is far larger — about 700.1× Citius Pharmaceuticals Inc's market cap, and Aegon Ltd. pays a 4.94% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AEG | CTXR | |
|---|---|---|
Market Cap | $14.01B | $20.01M |
Sector | Financials | Health |
52-Week High | $9.53 | $1.82 |
52-Week Low | $6.79 | $0.48 |
Enterprise Value | $15.16B | $16.23M |
Dividend Yield | 4.94% | — |
Trailing returns across standard periods
Latest headlines on both assets
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →